Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04923867 · ClinicalTrials.gov registry record
Suturable DuraGen™ PMCF Study
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 106
- Enrollment target
NCT04923867 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 106 participants.
The verdict
NCT04923867 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.
Interventions
- DEVICE Suturable DuraGen™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2024-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04923867
The ClinicalTrials.gov registry entry for NCT04923867 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Suturable DuraGen™ is the first listed.
NCT04923867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04923867 about?
NCT04923867 is a clinical study titled "Suturable DuraGen™ PMCF Study". The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.
What is the current status of trial NCT04923867?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2021-04-28. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT04923867?
The interventions under investigation include: Suturable DuraGen™ (DEVICE).
Who is sponsoring clinical trial NCT04923867?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.